4//SEC Filing
FIVE PRIME THERAPEUTICS INC 4
Accession 0001209191-16-149265
CIK 0001175505operating
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 1:53 PM ET
Size
12.1 KB
Accession
0001209191-16-149265
Insider Transaction Report
Form 4
Jensen Peder
Director
Transactions
- Exercise/Conversion
Common Stock
2016-11-09$5.54/sh+4,065$22,520→ 4,065 total - Exercise/Conversion
Common Stock
2016-11-09$7.26/sh+4,065$29,512→ 8,130 total - Sale
Common Stock
2016-11-09$55.30/sh−8,130$449,589→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2016-11-09+4,065→ 0 totalExercise: $7.26Exp: 2023-07-18→ Common Stock (4,065 underlying) - Exercise/Conversion
Stock Option (right to buy)
2016-11-09+4,065→ 0 totalExercise: $5.54Exp: 2022-07-10→ Common Stock (4,065 underlying)
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on April 5, 2016.
- [F2]This option is fully vested and immediately exercisable.
Documents
Issuer
FIVE PRIME THERAPEUTICS INC
CIK 0001175505
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001175505
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 1:53 PM ET
- Size
- 12.1 KB